<p>ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy</p>

Original Research

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy

Total article views		HTML views	PDF downloads	Totals
13,443	Dovepress*	10,370+	1,240	11,610
	PubMed Central*	3,073	1,049	4,122
	Totals	13,443	2,289	15,732
*Since 14 November 2019

Total mentioned	Facebook	Delicious	Reddit	Twitter	Others
28	1	0	0	5	22